Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
United States of America US
Employees
11 000
IPO date
Jul 6, 1965

Revvity makes tools and tests used in laboratories that study biology and diagnose disease. Its products include laboratory instruments, reagents, assay kits, software, and related services that help customers measure biological signals, run genetic and biochemical tests, and analyze results. The company serves drug developers, biotech and academic research labs, and clinical and public health laboratories.

The company makes money in a few main ways: it sells instruments and software systems upfront, and it also sells the consumable chemicals, test kits, and service contracts that customers keep buying after the equipment is installed. That gives Revvity a mix of one-time sales and recurring revenue tied to the ongoing use of its platforms. In diagnostics, its products help labs detect and monitor disease; in research, they help scientists discover and develop new medicines.

What makes Revvity’s business model distinct is that it sits in the middle of the lab workflow. It does not just sell standalone equipment; it sells the tools, tests, and support that labs use repeatedly to generate data and make decisions. That makes the company an important supplier to both healthcare testing and life sciences research, where customers care about accuracy, reliability, and easy-to-run workflows.

Revvity Inc Investor Relations

Address
77 4Th Avenue
Waltham, Massachusetts
United States of America

Business Segments

Discovery and analytical solutions

This segment sells instruments, reagents, software, and lab services that help scientists study biology, chemistry, and disease in research labs. It supports drug discovery, genomics, and other laboratory testing workflo...

Customers and revenue model

Diagnostics

This segment provides tests, instruments, reagents, and automation systems used to screen patients, confirm diagnoses, and support prenatal, newborn, and disease testing in clinical labs.

Customers and revenue model

Management

Dr. Prahlad R. Singh Ph.D.

CEO, President & Director

Biography unavailable

Mr. Maxwell Krakowiak

Senior VP & CFO

Biography unavailable

Mr. Tajinder S. Vohra

Senior Vice President of Global Operations

Biography unavailable

Mr. Joel S. Goldberg

Senior VP of Administration, General Counsel & Secretary

Biography unavailable

Ms. Miriame Victor

Senior VP & Chief Commercial Officer

Biography unavailable

Mr. Andrew Okun

VP, Chief Accounting Officer & Treasurer

Biography unavailable

Mr. Bryan A. Kipp

Senior Vice President of Technology & Licensing

Biography unavailable

Ms. Madhuri Hegde FACMG, Ph.D.

Senior VP & Chief Scientific Officer

Biography unavailable

Mr. Stephen Barr Willoughby

Senior VP of Investor Relations & Head of ESG

Biography unavailable

Ms. Magali Four

Senior VP and Chief People & Culture Officer

Biography unavailable

1 / 10